Nestlé Health Science-backed study finds heart health and weight benefits of clinical program

19 Dec 2023 — A clinical trial funded by Nestlé Health Science reveals that the company’s Optifast meal replacement program led to more significant reductions in weight, blood pressure, cholesterol and projected cardiovascular disease risk than a low-calorie diet plan. 

Available at US weight loss clinics, the program uses a meal replacement plan, combined with education and support, to help people transition to self-prepared daily meals.